Cargando…

Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?

BACKGROUND: Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) differ in treatment and prognosis, warranting an effective differential diagnosis between them. The LR-M category in the contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) was set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jia-Yan, Li, Jia-Wu, Ling, Wen-Wu, Li, Tao, Luo, Yan, Liu, Ji-Bin, Lu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385563/ https://www.ncbi.nlm.nih.gov/pubmed/32774068 http://dx.doi.org/10.3748/wjg.v26.i27.3938

Ejemplares similares

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound
por: Chen, Li-Da, et al.
Publicado: (2018)

Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection
por: Li, Hui, et al.
Publicado: (2020)

Histopathological characteristics of needle core biopsy and surgical specimens from patients with solitary hepatocellular carcinoma or intrahepatic cholangiocarcinoma
por: Wu, Ju-Shan, et al.
Publicado: (2019)

Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection
por: Deng, Li-Ming, et al.
Publicado: (2021)

Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection
por: Wang, Jin-Ju, et al.
Publicado: (2020)

Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study
por: Yuan, Zi-Bo, et al.
Publicado: (2022)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Contrast-enhanced ultrasound imaging for intestinal lymphoma
por: Cui, Ning-Yi, et al.
Publicado: (2021)

Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
por: Tu, Hai-Bin, et al.
Publicado: (2021)

Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients
por: Feng, Jian, et al.
Publicado: (2022)

Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years
por: Kim, Dong Kyun, et al.
Publicado: (2019)

Detailed Analysis of Temporal Features on Contrast Enhanced Ultrasound May Help Differentiate Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma in Cirrhosis
por: Li, Rui, et al.
Publicado: (2014)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound
por: Wu, Xiao-Feng, et al.
Publicado: (2020)

Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection
por: Li, Shu-Qun, et al.
Publicado: (2023)

Contrast-enhanced ultrasound manifestations of synchronous combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: A case report
por: Gao, Ling, et al.
Publicado: (2022)

Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma
por: Tang, You-Yin, et al.
Publicado: (2021)

Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
por: Chen, Li-Xing, et al.
Publicado: (2020)

Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm)
por: Mei, Qi, et al.
Publicado: (2022)

Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma
por: Sempokuya, Tomoki, et al.
Publicado: (2020)

Differentiating malignant and benign focal liver lesions in children using CEUS LI-RADS combined with serum alpha-fetoprotein
por: Jiang, Zhen-Peng, et al.
Publicado: (2022)

Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision
por: Duong, Nikki, et al.
Publicado: (2022)

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study
por: Zhang, Ge, et al.
Publicado: (2022)

Effect of contrast-enhanced ultrasound on differential diagnosis of intrahepatic cholangiocarcinoma and arterial phase enhanced hepatic inflammatory lesions
por: Yin, Shanshan, et al.
Publicado: (2017)

Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma
por: Li, Yuan-Ming, et al.
Publicado: (2022)

Differential diagnosis between hepatic alveolar echinococcosis and intrahepatic cholangiocarcinoma with conventional ultrasound and contrast-enhanced ultrasound
por: Wa, Zeng-Cheng, et al.
Publicado: (2020)

Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis
por: Vidili, Gianpaolo, et al.
Publicado: (2022)

Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
por: Jiang, Tao, et al.
Publicado: (2021)

Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline
por: Guo, Le-Hang, et al.
Publicado: (2015)

Instant evaluation of contrast enhanced endoscopic ultrasound helps to differentiate various solid pancreatic lesions in daily routine
por: Kannengiesser, Klaus, et al.
Publicado: (2019)

Contrast-enhanced Ultrasound Features of Intrahepatic Cholangiocarcinoma: A New Perspective
por: Chen, Tianjiao, et al.
Publicado: (2019)

Preoperative differentiation of hepatocellular carcinoma with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma on contrast-enhanced MRI
por: Zhang, Sisi, et al.
Publicado: (2022)

Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
por: Liu, Ning, et al.
Publicado: (2023)

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019)

Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
por: Deng, Peng-Zhan, et al.
Publicado: (2022)

Impact of contrast-enhanced ultrasound in patients with renal function impairment
por: Girometti, Rossano, et al.
Publicado: (2017)

Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma
por: Shin, Seung Kak, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ek5qa2h6rilpr7humrju9sjjtc